loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Pharmaceutical Excipients offered by Seppic? Find Interferon alpha-2b, Recombinant to address your drug delivery challenges on PharmaCompass.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    View Presentation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Interferon alpha-2b, Recombinant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 24Seppic

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Seppic

    MONTANOX 80 PHA PREMIUM

    arrow
    The Pharmacy Technology
    Not Confirmed

    Seppic

    France
    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Paste, Shampoo, Solution, Syrup, Tablet

    Grade : Topical, Oral

    Brand Name : MONTANOX 80 PHA PREMIUM

    Application : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical

    Excipient Details : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer

    Pharmacopoeia Ref : Ph.Eur, USP-NF

    Technical Specs : HLB: 15, EO: 20; EXCiPACT

    Ingredient(s) : Polysorbate 80

    Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Paste, Shampoo, Solution, Syrup, Tablet

    Grade : Topical, Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Polysorbate 80

    Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Paste, Shampoo, Solution, Syrup, Tablet

    Category : Film Formers & Plasticizers, Solubilizers, Surfactant & Foaming Agents, Topical

    Brand : MONTANOX 80 PHA PREMIUM

    Applications : Non-Ionic Hydrophilic Surfactant, Emulsifier, Solubilizer

    Pharmacopoeia Ref : Ph.Eur, USP-NF

    Technical Specs : HLB: 15, EO: 20; EXCiPACT

    Grade : Topical, Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Seppic

    MONTANOX 80 PPI

    arrow
    The Pharmacy Technology
    Not Confirmed

    03

    Seppic

    MONTANOX 80 API

    arrow
    The Pharmacy Technology
    Not Confirmed

    04

    Seppic

    MONTANOX 80 LPI

    arrow
    The Pharmacy Technology
    Not Confirmed

    05

    Seppic

    MONTANOX 80 VG DF RPR D

    arrow
    The Pharmacy Technology
    Not Confirmed

    06

    Seppic

    SEPITRAP 80

    arrow
    The Pharmacy Technology
    Not Confirmed